| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/19/2006 | US7108847 Delivery of muscle relaxants through an inhalation route |
| 09/19/2006 | CA2292558C 1-amino-alkylcyclohexane nmda receptor antagonists |
| 09/19/2006 | CA2139877C Hematopoietic facilitatory cells and their uses |
| 09/19/2006 | CA2083493C Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 09/14/2006 | WO2006096270A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/14/2006 | WO2006095906A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | WO2006095723A1 Antiallergic drug |
| 09/14/2006 | WO2006095666A1 Pyrazolopyridine-4-yl pyridazinone derivative and addition salt thereof, and pde inhibitor comprising the derivative or salt as active ingredient |
| 09/14/2006 | WO2006095559A1 USE OF Fgf21 AS HEMATOPOIETIC FACTOR |
| 09/14/2006 | WO2006095183A1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/14/2006 | WO2006094600A1 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and raf kinase modulators |
| 09/14/2006 | WO2006070325A3 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
| 09/14/2006 | WO2006068987A3 Uses of il-23 antagonists in the treatment of diabetes mellitus |
| 09/14/2006 | WO2004062619A3 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 09/14/2006 | US20060205809 Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 09/14/2006 | US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205743 Protein kinase inhibitors |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205723 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060205711 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | US20060205659 Peptide radical having 5-25 amino acids with its N-terminus capped with a monoester of fumaric acid; used to treat autoimmune diseases, mitochondrial diseases, and NF-kappaB mediated diseases and in transplantation medicine |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205033 Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060205016 Protein a based binding domains with desirable activities |
| 09/14/2006 | US20060204587 Use of film coating as taste-masking coating of oral dosage forms |
| 09/14/2006 | US20060204516 Compositions and methods for enhancing the immunogenicity of antigens |
| 09/14/2006 | US20060204508 Treatment of autoimmune diseases using an activator for the notch signalling pathway |
| 09/14/2006 | US20060204501 Drug for cancer therapy |
| 09/14/2006 | CA2601980A1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/14/2006 | CA2600836A1 Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent |
| 09/14/2006 | CA2600630A1 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and raf kinase modulators |
| 09/14/2006 | CA2599879A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | CA2597485A1 Methods and compositions for modulating tweak and fn14 activity |
| 09/14/2006 | CA2596830A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1700868A2 A method for removing an antibody from blood or plasma |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1699925A1 Il-23 and its receptor; related reagents and methods |
| 09/13/2006 | EP1699823A2 Use of il-18 binding protein in inflammations |
| 09/13/2006 | EP1699788A2 Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides |
| 09/13/2006 | EP1699467A1 Aminoglycoside antibiotics for use as vap-1/ssao inhibitors |
| 09/13/2006 | EP1699398A2 Enhancement of immune responses |
| 09/13/2006 | EP1532145B1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 09/13/2006 | EP1497274B1 Terphenyl derivatives, preparation thereof, compositions containing same |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1385452B1 Ophthalmic drug delivery device |
| 09/13/2006 | EP1366074B1 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/13/2006 | EP1343486B1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP1200040B8 Two-component composition for cosmetic or pharmaceutical use |
| 09/13/2006 | EP1196579B1 Tryptase inhibitor |
| 09/13/2006 | EP1095062B1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 09/13/2006 | EP1087951B9 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 09/13/2006 | EP1064025B1 Combined vaccine compositions |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | EP0832093B1 Expression of lipoproteins |
| 09/13/2006 | EP0811065B1 Antagonists of interleukin-15 |
| 09/13/2006 | CN1832960A Immunomodulating compositions, uses therefor and processes for their production |
| 09/13/2006 | CN1832956A Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same |
| 09/13/2006 | CN1832945A Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 09/13/2006 | CN1832929A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/13/2006 | CN1832925A New p2x7 receptor avtagonists and their use |
| 09/13/2006 | CN1832728A Process for producing drug ultramicroparticle and apparatus therefor |
| 09/13/2006 | CN1831012A Immunological adjuvant with immunity vegulating agent for treating and preventing diabetic from insulin-dependent |
| 09/13/2006 | CN1830316A Food mother material and its making method |
| 09/13/2006 | CN1830313A SOD cordyceps sinensis regulating water |
| 09/13/2006 | CN1274717C Immune suppression fusion protein, its coded nucleic acid and application |
| 09/13/2006 | CN1274703C Unsaturated pyranocarbonoside compounds and preparing process thereof |
| 09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 09/13/2006 | CN1274667C Cycloalkenone derivative |
| 09/13/2006 | CN1274364C Crosslinker of anti-FcªŠRIª‡ monoclonal antibody Fab and tripterine |
| 09/13/2006 | CN1274322C Application of injection containing radix ginseng |
| 09/13/2006 | CN1274320C Notoginseng ginkgo health care food and its preparation method |
| 09/13/2006 | CN1274309C Enteric-coated formulation of glycyrrhizic acid and its salt and its preparing method |
| 09/13/2006 | CN1274294C Novel cyclosporin analog microemulsion preconcentrates |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105675 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence |
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105651 Nucleotide sequences coding polypeptide for use in the treatment of cancer, inflammation and infection; for use as pesticide and antibiotic |
| 09/12/2006 | US7105644 Secreted protein HHTLF25 antibodies |
| 09/12/2006 | US7105572 Cardiovascular disorders |
| 09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
| 09/12/2006 | US7105552 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 09/12/2006 | US7105550 2,4-disubstituted thiazolyl derivatives |
| 09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | US7105328 Methods for screening for compounds that modulate pd-1 signaling |
| 09/12/2006 | US7105162 Peptide or protein from a pathogenic or tumor agent having immunomodulatory activity with an adjuvant capable of increasing the binding of the peptide to the cells of the individual or increasing the entry of the peptide into the cells; strengthening immunomodulatory activity; polyamino acids adjuvants |